Performance evaluation of Truenat™ Beta CoV & Truenat™ SARS-CoV-2 point-of-care assays for coronavirus disease 2019

BACKGROUND & OBJECTIVES: The rapid diagnosis of coronavirus disease 2019 (COVID-19) is a significant step towards the containment of the virus. The surge of COVID-19 cases in India and across the globe necessitates a rapid and sensitive molecular assay. Rapid point-of-care (PoC) assays (Truenat...

Descripción completa

Detalles Bibliográficos
Autores principales: Basawarajappa, Shantala Gowdara, Rangaiah, Ambica, Padukone, Shashiraja, Yadav, Pragya D., Gupta, Nivedita, Shankar, Sathyanarayan Muthur
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184085/
https://www.ncbi.nlm.nih.gov/pubmed/33818471
http://dx.doi.org/10.4103/ijmr.IJMR_2363_20

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184085/
https://www.ncbi.nlm.nih.gov/pubmed/33818471
http://dx.doi.org/10.4103/ijmr.IJMR_2363_20

Ejemplares similares